Literature DB >> 6196105

Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules.

D Naor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6196105     DOI： 10.1007/bf00199898

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  68 in total

1.  The fine specificity of regulatory T cells. IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response.

Authors:  L Adorini; M Harvey; E E Sercarz
Journal:  Eur J Immunol       Date:  1979-11       Impact factor: 5.532

2.  Tumor-protective and -facilitating antigens from 3 M KCl-solubilized tumor extracts.

Authors:  H Yamagishi; N R Pellis; B D Kahan
Journal:  J Surg Res       Date:  1979-04       Impact factor: 2.192

3.  Amputation of a suppressor determinant on lysozyme reveals underlying T-cell reactivity to other determinants.

Authors:  R L Yowell; B A Araneo; A Miller; E E Sercarz
Journal:  Nature       Date:  1979-05-03       Impact factor: 49.962

4.  In vitro expression of suppressogenic and enhancing activities in human colon cancer cells.

Authors:  B H Tom; C M Macek; C Subramanian; A L Miller; J Sengupta
Journal:  J Biol Response Mod       Date:  1984-08

Review 5.  Role of self MHC carriers in tolerance and the immune response.

Authors:  D W Scott; C Long; J J Jandinski; J T Li
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 6.  Myelin basic protein: structure, function and antigenic determinants.

Authors:  G A Hashim
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

7.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

8.  Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorigenic YAC cells.

Authors:  B Devens; O Deutsch; Y Avraham; D Naor
Journal:  Immunobiology       Date:  1981       Impact factor: 3.144

9.  The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon.

Authors:  G Senyk; E B Williams; D E Nitecki; J W Goodman
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

10.  The requirement of more than one antigenic determinant for immunogenicity.

Authors:  K Rajewsky; V Schirrmacher; S Nase; N K Jerne
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  8 in total

1.  Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97.

Authors:  S L Hu; G D Plowman; P Sridhar; U S Stevenson; J P Brown; C D Estin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

Review 2.  Cellular interactions in metastasis.

Authors:  F R Miller; G H Heppner
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

3.  Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus.

Authors:  J L Lathey; B T Rouse; D E Wiley; R J Courtney
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

4.  Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.

Authors:  H H Sedlacek; G Hagmayer; F R Seiler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).

Authors:  R Sharon; D Naor
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responses.

Authors:  B Y Klein; S Frenkel; D Naor
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 7.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor.

Authors:  R C Bocian; S Dray; S Ben-Efraim; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.